These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1083 related items for PubMed ID: 18670862

  • 1. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
    Hsieh HJ, Lin SH, Lin KH, Lee CY, Chang CP, Wang SJ.
    Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
    [Abstract] [Full Text] [Related]

  • 2. [Comparative analysis of the informative value of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography in the differential diagnosis of solitary lung masses].
    Tlostanova MS, Avetisian AO, Kozak AR.
    Vestn Rentgenol Radiol; 2014 Jul; (3):13-9. PubMed ID: 25782293
    [Abstract] [Full Text] [Related]

  • 3. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography.
    Bar-Shalom R, Kagna O, Israel O, Guralnik L.
    Cancer; 2008 Dec 01; 113(11):3213-21. PubMed ID: 18924145
    [Abstract] [Full Text] [Related]

  • 4. Solitary pulmonary nodules: morphological and metabolic characterisation by FDG-PET-MDCT.
    Orlacchio A, Schillaci O, Antonelli L, D'Urso S, Sergiacomi G, Nicolì P, Simonetti G.
    Radiol Med; 2007 Mar 01; 112(2):157-73. PubMed ID: 17361379
    [Abstract] [Full Text] [Related]

  • 5. A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3'-deoxy-3'-18F-fluorothymidine and 18F-FDG.
    Tian J, Yang X, Yu L, Chen P, Xin J, Ma L, Feng H, Tan Y, Zhao Z, Wu W.
    J Nucl Med; 2008 Feb 01; 49(2):186-94. PubMed ID: 18199618
    [Abstract] [Full Text] [Related]

  • 6. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
    Messa C, Ceresoli GL, Rizzo G, Artioli D, Cattaneo M, Castellone P, Gregorc V, Picchio M, Landoni C, Fazio F.
    Q J Nucl Med Mol Imaging; 2005 Sep 01; 49(3):259-66. PubMed ID: 16172572
    [Abstract] [Full Text] [Related]

  • 7. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT.
    Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Collins DA, Kasperbauer JL, Strome SE, Reading CC, Hay ID, Lowe VJ.
    Nucl Med Commun; 2007 May 01; 28(5):373-81. PubMed ID: 17414887
    [Abstract] [Full Text] [Related]

  • 8. Comparison of lesion-to-cerebellum uptake ratios and standardized uptake values in the evaluation of lung nodules with 18F-FDG PET.
    Obrzut S, Pham RH, Vera DR, Badran K, Hoha CK.
    Nucl Med Commun; 2007 Jan 01; 28(1):7-13. PubMed ID: 17159543
    [Abstract] [Full Text] [Related]

  • 9. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.
    Ann Surg; 2007 Dec 01; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [Abstract] [Full Text] [Related]

  • 10. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
    Ohno Y, Koyama H, Takenaka D, Nogami M, Maniwa Y, Nishimura Y, Ohbayashi C, Sugimura K.
    J Magn Reson Imaging; 2008 Jun 01; 27(6):1284-95. PubMed ID: 18504748
    [Abstract] [Full Text] [Related]

  • 11. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.
    Evangelista L, Panunzio A, Polverosi R, Pomerri F, Rubello D.
    AJR Am J Roentgenol; 2014 Mar 01; 202(3):507-14. PubMed ID: 24555586
    [Abstract] [Full Text] [Related]

  • 12. Granulomatous disease: is it a nuisance or an asset during PET/computed tomography evaluation of lung cancers?
    Chundru S, Wong CY, Wu D, Balon H, Palka J, Chang CY, Gaskill M, Cheng CY, Huang WS, Fink-Bennett D.
    Nucl Med Commun; 2008 Jul 01; 29(7):623-7. PubMed ID: 18528184
    [Abstract] [Full Text] [Related]

  • 13. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
    Zhang M, Jiang X, Zhang M, Xu H, Zhai G, Li B.
    J Nucl Med; 2009 Apr 01; 50(4):506-12. PubMed ID: 19289438
    [Abstract] [Full Text] [Related]

  • 14. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection.
    Quaia E, Tona G, Gelain F, Lubin E, Pizzolato R, Boscolo E, Bussoli L.
    Acta Radiol; 2008 Nov 01; 49(9):995-1004. PubMed ID: 18651256
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
    Castellucci P, Perrone AM, Picchio M, Ghi T, Farsad M, Nanni C, Messa C, Meriggiola MC, Pelusi G, Al-Nahhas A, Rubello D, Fazio F, Fanti S.
    Nucl Med Commun; 2007 Aug 01; 28(8):589-95. PubMed ID: 17625380
    [Abstract] [Full Text] [Related]

  • 16. 18F-FDG PET and PET/CT in Burkitt's lymphoma.
    Karantanis D, Durski JM, Lowe VJ, Nathan MA, Mullan BP, Georgiou E, Johnston PB, Wiseman GA.
    Eur J Radiol; 2010 Jul 01; 75(1):e68-73. PubMed ID: 19716248
    [Abstract] [Full Text] [Related]

  • 17. Prosthetic vascular graft infection: the role of 18F-FDG PET/CT.
    Keidar Z, Engel A, Hoffman A, Israel O, Nitecki S.
    J Nucl Med; 2007 Aug 01; 48(8):1230-6. PubMed ID: 17631553
    [Abstract] [Full Text] [Related]

  • 18. [Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].
    Cai L, Gao S, Li DC, Li YS, Chen QS, Xing XL.
    Zhonghua Zhong Liu Za Zhi; 2009 Feb 01; 31(2):134-8. PubMed ID: 19538892
    [Abstract] [Full Text] [Related]

  • 19. 18F-FDG-PET/CT as an indicator for resection of pulmonary epithelioid hemangioendothelioma.
    Watanabe S, Yano F, Kita T, Soga S, Shinmoto H, Kosuda S, Ozeki Y, Aida S, Sakata I.
    Ann Nucl Med; 2008 Jul 01; 22(6):521-4. PubMed ID: 18670859
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer.
    Sato M, Okumura T, Kaito K, Kiyoshima M, Asato Y, Uchiumi K, Iijima H, Hashimoto I, Kaburagi T, Amemiya R.
    Ann Nucl Med; 2009 Jan 01; 23(1):49-57. PubMed ID: 19205838
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 55.